DEPO Description — Assertio Therapeutics Inc
Depomed is a pharmaceutical company focused on pain and other central nervous system conditions. Co.'s business includes the following products marketed in the U.S. for various pain states: Gralise®, which is a once-daily product for the management of postherpetic neuralgia; CAMBIA®, which is a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks; Zipsor®, which is a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain; NUCYNTA® ER, which is a product for the management of pain severe enough to require daily, including neuropathic pain; and NUCYNTA® IR, which is for the management of moderate to severe acute pain in adults.